The global Major Histocompatibility Complex (MHC) Tetramer market was valued at US$ 11.9 million in 2024 and is anticipated to reach US$ 20.7 million by 2031, witnessing a CAGR of 8.2% during the forecast period 2025-2031. The major histocompatibi...
researchreports
Markdown supported · ⌘↵ to post
No responses yet.